Breast – Invasive breast cancer of no special type (NST) with faint TLE1 staining of few tumor cells
Breast – Invasive breast cancer of no special type (NST) with faint TLE1 staining of few tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of a fraction of tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of a fraction of tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of tumor cells
Breast – Invasive breast cancer of no special type (NST) with weak to moderate TLE1 staining of tumor cells
Breast – Invasive lobular breast cancer with strong TLE1 staining of all tumor cells
Breast – Invasive lobular breast cancer with strong TLE1 staining of all tumor cells
Colon – Colorectal adenocarcinoma with moderate TLE1 staining of tumor cells
Colon – Colorectal adenocarcinoma with moderate TLE1 staining of tumor cells
Colon – Colorectal adenocarcinoma with weak to moderate TLE1 positivity of tumor cells
Colon – Colorectal adenocarcinoma with weak to moderate TLE1 positivity of tumor cells
Esophagus – Adenocarcinoma with faint TLE1 immunostaining of few tumor cells
Esophagus – Adenocarcinoma with faint TLE1 immunostaining of few tumor cells
Esophagus – Squamous cell carcinoma with variable, weak to strong TLE1 staining of tumor cells
Esophagus – Squamous cell carcinoma with variable, weak to strong TLE1 staining of tumor cells
Kidney – Oncocytoma with faint TLE1 immunostaining of most tumor cells
Kidney – Oncocytoma with faint TLE1 immunostaining of most tumor cells
Kidney – Papillary renal cell carcinoma with weak TLE1 staining of most tumor cells
Kidney – Papillary renal cell carcinoma with weak TLE1 staining of most tumor cells
Kidney – TLE1 negative clear cell carcinoma. TLE1 staining is prominent in tumor-associated endothelial cells
Kidney – TLE1 negative clear cell carcinoma. TLE1 staining is prominent in tumor-associated endothelial cells
Oral cavity – Squamous cell carcinoma with strong TLE1 immunostaining of tumor cells
Oral cavity – Squamous cell carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Clear cell carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Clear cell carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Endometroid carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Endometroid carcinoma with strong TLE1 immunostaining of tumor cells
Ovary – Serous high-grade carcinoma with faint TLE1 staining of a small subset of tumor cells
Ovary – Serous high-grade carcinoma with faint TLE1 staining of a small subset of tumor cells
Pharynx – Squamous cell carcinoma with moderate to strong TLE1 staining of most tumor cells
Pharynx – Squamous cell carcinoma with moderate to strong TLE1 staining of most tumor cells
Pharynx – Squamous cell carcinoma with weak TLE1 positivity of a fraction of tumor cells
Pharynx – Squamous cell carcinoma with weak TLE1 positivity of a fraction of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with weak TLE1 immunostaining of tumor cells. Tumor cell staining is weaker than in adjacent normal acinar cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with weak TLE1 immunostaining of tumor cells. Tumor cell staining is weaker than in adjacent normal acinar cells
Prostate – Adenocarcinoma (Gleason 4+4=8) with moderate to strong TLE1 immunostaining of tumor cells
Prostate – Adenocarcinoma (Gleason 4+4=8) with moderate to strong TLE1 immunostaining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 immunostaining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 immunostaining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 positivity of all tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 positivity of all tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 staining of tumor cells
Soft tissue – Synovial sarcoma with strong TLE1 staining of tumor cells
Soft tissue –Synovial sarcoma exhibiting strong TLE1 staining of tumor cells
Soft tissue –Synovial sarcoma exhibiting strong TLE1 staining of tumor cells
Thyroid – TLE1 negative follicular carcinoma
Thyroid – TLE1 negative follicular carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with moderate TLE1 positivity of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with moderate TLE1 positivity of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with weak TLE1 staining of a fraction of tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with weak TLE1 staining of a fraction of tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with faint TLE1 staining of most tumor cells
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with faint TLE1 staining of most tumor cells